SpikImm
- Biotech or pharma, therapeutic R&D
SpkImm is a partnership between Institut Pastteur & Truffle Capital focussed on delivering long acting passive immunity for immunocompromised patients. The compamy is now focussed on preventing serious viral infections in immunocompromised patients. The lead asset is against BKV in Renal Transplant, and against JCV which causes PML in at risk patients with near 100% mortality .
Address
ParisIle de France
France
)
)
){kind=logo}
){kind=logo}
){kind=logo}